[Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO].
AUO. AUO@MeckEvidence.de
H
H
Rexer
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D000077557:Ibandronic Acid; D008297:Male; D008942:Mitoxantrone / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D018579:Patient Selection; D011239:Prednisolone / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D004164:Diphosphonates; D011239:Prednisolone; D008942:Mitoxantrone; D000077557:Ibandronic Acid